GlaxoSmithKline LLC et al v. Sun Pharmaceutical Industries Ltd.
| GlaxoSmithKline LLC, TESARO, Inc. and Merck Sharp & Dohme LLC |
| Sun Pharmaceutical Industries Ltd. |
| Sun Pharmaceutical Industries Ltd. |
| GlaxoSmithKline LLC, Merck Sharp & Dohme LLC and TESARO, Inc. |
| 1:2025cv01170 |
| September 18, 2025 |
| U.S. District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 1 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 13, 2026. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 43
PROTECTIVE ORDER. Signed by Judge Colm F. Connolly on 3/13/2026. (kmd)
|
| Filing 42 PROPOSED ORDER Stipulated Protective Order by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc.. (Joyce, Alexandra) |
|
Filing 41
SO ORDERED, re #40 STIPULATION TO EXTEND TIME the deadline for the parties to file a proposed protective order to March 13, 2026. Signed by Judge Colm F. Connolly on 3/4/2026. (mws)
|
| Filing 40 STIPULATION TO EXTEND TIME the deadline for the parties to file a proposed protective order to March 13, 2026 - filed by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc.. (Joyce, Alexandra) |
| Filing 39 NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories filed by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc..(Silver, Daniel) |
| Filing 38 NOTICE OF SERVICE of Defendant's Response to Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-41) filed by Sun Pharmaceutical Industries Ltd..(Mackrides, Daniel) |
| Filing 37 NOTICE OF SERVICE of Plaintiffs' Rule 26(a) Initial Disclosures filed by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc..(Silver, Daniel) |
| Filing 36 ANSWER to #12 Answer to Complaint, Counterclaim by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc..(Silver, Daniel) |
| Filing 35 NOTICE OF SERVICE of Defendant, Sun Pharmaceutical Industries Ltd.'s Initial Disclosures Under Rule 26(A)(1) filed by Sun Pharmaceutical Industries Ltd..(Mackrides, Daniel) |
|
Filing 34
SO ORDERED, re #33 STIPULATION TO EXTEND TIME for parties to file their proposed Protective Order to March 5, 2026, filed by Sun Pharmaceutical Industries Ltd. Signed by Judge Colm F. Connolly on 2/26/2026. (kmd)
|
| Filing 33 STIPULATION TO EXTEND TIME for parties to file their proposed Protective Order to March 5, 2026 - filed by Sun Pharmaceutical Industries Ltd.. (Mackrides, Daniel) |
| Filing 32 NOTICE of Partial Dismissal of Counterclaims VII and VIII by Sun Pharmaceutical Industries Ltd. (Gaza, Anne) |
| Filing 31 NOTICE OF SERVICE of 1) Plaintiffs' Initial Disclosures Pursuant to Paragraph 4(a) of the Default Standard for Discovery and (2) Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc..(Silver, Daniel) |
| Filing 30 NOTICE OF SERVICE of Defendant Sun Pharmaceutical Industries Ltd.'s Initial Disclosures Under Paragraph 3 of the Default Standard for Discovery of Electronically Stored Information filed by Sun Pharmaceutical Industries Ltd..(Mackrides, Daniel) |
| Pro Hac Vice Attorney Reshma C. Gogineni for GlaxoSmithKline LLC, Merck Sharp & Dohme LLC & TESARO, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (slk) |
|
SO ORDERED, re #28 MOTION for Pro Hac Vice Appearance of Attorney Reshma C. Gogineni, filed by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc. Ordered by Judge Colm F. Connolly on 2/20/2026. (kmd)
|
| Filing 29 Pro Hac Vice Fee - Credit Card Payment received for Reshma C. Gogineni. ( re #28 MOTION for Pro Hac Vice Appearance of Attorney Reshma C. Gogineni )( Payment of $ 50, receipt number ADEDC-4904527).(Silver, Daniel) |
| Filing 28 MOTION for Pro Hac Vice Appearance of Attorney Reshma C. Gogineni - filed by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc.. (Attachments: #1 Certification for Reshma C. Gogineni)(Silver, Daniel) |
|
Filing 27
SO ORDERED, re #26 STIPULATION TO EXTEND TIME the deadline to answer, move, or otherwise respond to Defendant Sun Pharmaceutical Industries Ltd.'s Counterclaims to February 26, 2026, filed by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc. Reset Answer Deadlines: GlaxoSmithKline LLC answer due 2/26/2026; Merck Sharp & Dohme LLC answer due 2/26/2026; TESARO, Inc. answer due 2/26/2026. Signed by Judge Colm F. Connolly on 2/5/2026. (kmd)
|
| Filing 26 STIPULATION TO EXTEND TIME the deadline to answer, move, or otherwise respond to Defendant Sun Pharmaceutical Industries Ltd.'s Counterclaims to February 26, 2026 - filed by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc.. (Joyce, Alexandra) |
| Filing 25 NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things filed by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc..(Silver, Daniel) |
|
Filing 24
SO ORDERED, re #23 STIPULATION TO EXTEND TIME the Deadline for Plaintiffs GlaxoSmithKline LLC, TESARO, Inc., and Merck Sharp & Dohme LLC to answer, move, or otherwise respond to Defendant Sun Pharmaceutical Industries Ltd.'s Counterclaims to February 12, 2026, filed by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc. Reset Answer Deadlines: GlaxoSmithKline LLC answer due 2/12/2026; Merck Sharp & Dohme LLC answer due 2/12/2026; TESARO, Inc. answer due 2/12/2026. Signed by Judge Colm F. Connolly on 1/27/2026. (kmd)
|
| Filing 23 STIPULATION TO EXTEND TIME the Deadline for Plaintiffs GlaxoSmithKline LLC, TESARO, Inc., and Merck Sharp & Dohme LLC to answer, move, or otherwise respond to Defendant Sun Pharmaceutical Industries Ltd.'s Counterclaims to February 12, 2026 - filed by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc.. (Silver, Daniel) |
|
Filing 22
SCHEDULING ORDER: Joinder of Parties due by 3/4/2027. Amended Pleadings due by 3/4/2027. Fact Discovery completed by 9/16/2027. Expert Discovery due by 3/9/2028. Joint Claim Construction Brief due by 3/4/2027. A Markman Hearing is set for 4/1/2027 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 6/26/2028. A Final Pretrial Conference is set for 7/17/2028 at 01:00 PM in Courtroom 4B before Judge Colm F. Connolly. A 5-Day Bench Trial is set to begin on 7/24/2028 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 1/23/2026. (mws)
|
| Filing 21 PROPOSED ORDER Stipulated Scheduling by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc.. (Joyce, Alexandra) |
| Remark: The January 27, 2026 Scheduling Conference is cancelled per the filing of a proposed scheduling order with no areas of dispute. (mws) |
|
Filing 20
Order Setting Telephonic Scheduling Conference: A Telephonic Scheduling Conference is set for 1/27/2026 at 02:00 PM before Judge Colm F. Connolly. If the parties have no disputes about the scheduling order, the Court will not require the parties to appear at a conference. Signed by Judge Colm F. Connolly on 1/5/2026. (mws)
|
|
Filing 19
SO ORDERED, re #18 STIPULATION TO EXTEND TIME for Plaintiffs GlaxoSmithKline, LLC, TERASO, Inc., and Merck Sharp & Dohme LLC to answer, move, or otherwise respond to Defendant Sun Pharmaceutical Industries, Ltd.'s Counterclaims (D.I. 12) to January 29, 2026, filed by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc. Set Answer Deadlines: GlaxoSmithKline LLC answer due 1/29/2026; Merck Sharp & Dohme LLC answer due 1/29/2026; TESARO, Inc. answer due 1/29/2026. Signed by Judge Colm F. Connolly on 1/5/2026. (kmd)
|
| Filing 18 STIPULATION TO EXTEND TIME for Plaintiffs GlaxoSmithKline, LLC, TERASO, Inc., and Merck Sharp & Dohme LLC to answer, move, or otherwise respond to Defendant Sun Pharmaceutical Industries, Ltd.'s Counterclaims (D.I. 12) to January 29, 2026 - filed by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc.. (Joyce, Alexandra) |
| Pro Hac Vice Attorney Seung Sub Kim,Jennell C. Bilek,Samuel T. Lockner,Katherine Chen for Sun Pharmaceutical Industries Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (jmn) |
| Filing 17 Pro Hac Vice Fee - Credit Card Payment received for Samuel T. Lockner, Jennell C. Bilek, Seung Sub Kim, and Katherine Q. Chen. ( re #16 MOTION for Pro Hac Vice Appearance of Attorney Samuel T. Lockner, Jennell C. Bilek, Seung Sub Kim, and Katherine Q. Chen )( Payment of $ 200, receipt number ADEDC-4862056).(Mackrides, Daniel) |
| Filing 16 MOTION for Pro Hac Vice Appearance of Attorney Samuel T. Lockner, Jennell C. Bilek, Seung Sub Kim, and Katherine Q. Chen - filed by Sun Pharmaceutical Industries Ltd.. (Mackrides, Daniel) |
| Filing 15 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Sun Pharmaceutical Industries Ltd.. (Gaza, Anne) |
| Filing 14 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: August 8, 2025. Date of Expiration of Patent: January 25, 2039.Thirty Month Stay Deadline: 2/8/2028. (Gaza, Anne) |
| Filing 13 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,071,623; 11,091,459; 11,673,877; 11,730,725 . (Gaza, Anne) |
| Filing 12 ANSWER to #1 Complaint , Separate Defenses, COUNTERCLAIM against GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc. by Sun Pharmaceutical Industries Ltd.. (Attachments: #1 Exhibit A)(Gaza, Anne) |
|
SO ORDERED, re #16 MOTION for Pro Hac Vice Appearance of Attorney Samuel T. Lockner, Jennell C. Bilek, Seung Sub Kim, and Katherine Q. Chen, filed by Sun Pharmaceutical Industries Ltd. Ordered by Judge Colm F. Connolly on 12/18/2025. (kmd)
|
| Filing 11 WAIVER OF SERVICE returned executed by TESARO, Inc., GlaxoSmithKline LLC, Merck Sharp & Dohme LLC: For Sun Pharmaceutical Industries Ltd. waiver sent on 9/19/2025, answer due 12/18/2025. (Silver, Daniel) |
| Pro Hac Vice Attorney Akkad Y. Moussa, Anna Wong, Christopher M Cherry, Christopher R. Noyes, Scott G. Greene, Timothy A. Cook for GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (scs) |
| Filing 10 Pro Hac Vice Fee - Credit Card Payment received for Akkad Y. Moussa. ( re #8 MOTION for Pro Hac Vice Appearance of Attorney Christopher R. Noyes, Scott G. Greene, Timothy A. Cook, Anna Wong, Christopher M. Cherry, and Akkad Y. Moussa )( Payment of $ 50, receipt number ADEDC-4796628).(Silver, Daniel) |
| Filing 9 Pro Hac Vice Fee - Credit Card Payment received for Christopher R. Noyes, Scott G. Greene, Timothy A. Cook, Anna Wong, and Christopher M. Cherry. ( re #8 MOTION for Pro Hac Vice Appearance of Attorney Christopher R. Noyes, Scott G. Greene, Timothy A. Cook, Anna Wong, Christopher M. Cherry, and Akkad Y. Moussa )( Payment of $ 250, receipt number ADEDC-4796620).(Silver, Daniel) |
| Filing 8 MOTION for Pro Hac Vice Appearance of Attorney Christopher R. Noyes, Scott G. Greene, Timothy A. Cook, Anna Wong, Christopher M. Cherry, and Akkad Y. Moussa - filed by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc.. (Attachments: #1 Certifications for Christopher R. Noyes, Scott G. Greene, Timothy A. Cook, Anna Wong, Christopher M. Cherry, and Akkad Y. Moussa)(Silver, Daniel) |
| Filing 7 STANDING ORDER REGARDING BRIEFING IN ALL CASES (mws) |
|
SO ORDERED, re #8 MOTION for Pro Hac Vice Appearance of Attorney Christopher R. Noyes, Scott G. Greene, Timothy A. Cook, Anna Wong, Christopher M. Cherry, and Akkad Y. Moussa, filed by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc. Ordered by Judge Colm F. Connolly on 9/24/2025. (kmd)
|
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (alb) |
| Filing 6 Summons Issued as to Sun Pharmaceutical Industries Ltd. on 9/19/2025. (oam) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,071,623; 11,091,459; 11,673,877. (oam) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent GlaxoSmithKline LLC for TESARO, Inc.; Corporate Parent GlaxoSmithKline plc. for GlaxoSmithKline LLC; Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme LLC filed by GlaxoSmithKline LLC, Merck Sharp & Dohme LLC, TESARO, Inc. (oam). |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 08/07/2025. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: No earlier than 2/7/2028. (oam) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam) |
| Filing 1 COMPLAINT against Sun Pharmaceutical Industries Ltd. (Filing fee $ 405, receipt number ADEDC-4793053) - filed by TESARO, Inc., GlaxoSmithKline LLC, Merck Sharp & Dohme LLC. (Attachments: #1 Exhibits A-C, #2 Civil Cover Sheet)(oam) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
